Literature DB >> 21873420

Identification and characterization of a new family of cell-penetrating peptides: cyclic cell-penetrating peptides.

Laura Cascales1, Sónia T Henriques, Markus C Kerr, Yen-Hua Huang, Matthew J Sweet, Norelle L Daly, David J Craik.   

Abstract

Cell-penetrating peptides can translocate across the plasma membrane of living cells and thus are potentially useful agents in drug delivery applications. Disulfide-rich cyclic peptides also have promise in drug design because of their exceptional stability, but to date only one cyclic peptide has been reported to penetrate cells, the Momordica cochinchinensis trypsin inhibitor II (MCoTI-II). MCoTI-II belongs to the cyclotide family of plant-derived cyclic peptides that are characterized by a cyclic cystine knot motif. Previous studies in fixed cells showed that MCoTI-II could penetrate cells but kalata B1, a prototypic cyclotide from a separate subfamily of cyclotides, was bound to the plasma membrane and did not translocate into cells. Here, we show by live cell imaging that both MCoTI-II and kalata B1 can enter cells. Kalata B1 has the same cyclic cystine knot structural motif as MCoTI-II but differs significantly in sequence, and the mechanism by which these two peptides enter cells also differs. MCoTI-II appears to enter via macropinocytosis, presumably mediated by interaction of positively charged residues with phosphoinositides in the cell membrane, whereas kalata B1 interacts directly with the membrane by targeting phosphatidylethanolamine phospholipids, probably leading to membrane bending and vesicle formation. We also show that another plant-derived cyclic peptide, SFTI-1, can penetrate cells. SFTI-1 includes just 14 amino acids and, with the exception of its cyclic backbone, is structurally very different from the cyclotides, which are twice the size. Intriguingly, SFTI-1 does not interact with any of the phospholipids tested, and its mechanism of penetration appears to be distinct from MCoTI-II and kalata B1. The ability of diverse disulfide-rich cyclic peptides to penetrate cells enhances their potential in drug design, and we propose a new classification for them, i.e. cyclic cell-penetrating peptides.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873420      PMCID: PMC3196123          DOI: 10.1074/jbc.M111.264424

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

Review 1.  How proteins produce cellular membrane curvature.

Authors:  Joshua Zimmerberg; Michael M Kozlov
Journal:  Nat Rev Mol Cell Biol       Date:  2006-01       Impact factor: 94.444

2.  Studies on the membrane interactions of the cyclotides kalata B1 and kalata B6 on model membrane systems by surface plasmon resonance.

Authors:  Hiroshi Kamimori; Kristopher Hall; David J Craik; Marie-Isabel Aguilar
Journal:  Anal Biochem       Date:  2005-02-01       Impact factor: 3.365

3.  Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.

Authors:  Sónia Troeira Henriques; Yen-Hua Huang; K Johan Rosengren; Henri G Franquelim; Filomena A Carvalho; Adam Johnson; Secondo Sonza; Gilda Tachedjian; Miguel A R B Castanho; Norelle L Daly; David J Craik
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

4.  Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure.

Authors:  J F Hernandez; J Gagnon; L Chiche; T M Nguyen; J P Andrieu; A Heitz; T Trinh Hong; T T Pham; D Le Nguyen
Journal:  Biochemistry       Date:  2000-05-16       Impact factor: 3.162

5.  Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells.

Authors:  Fabienne Rayne; Solène Debaisieux; Hocine Yezid; Yea-Lih Lin; Clément Mettling; Karidia Konate; Nathalie Chazal; Stefan T Arold; Martine Pugnière; Françoise Sanchez; Anne Bonhoure; Laurence Briant; Erwann Loret; Christian Roy; Bruno Beaumelle
Journal:  EMBO J       Date:  2010-03-11       Impact factor: 11.598

6.  Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I.

Authors:  Jeffrey Austin; Wan Wang; Swamy Puttamadappa; Alexander Shekhtman; Julio A Camarero
Journal:  Chembiochem       Date:  2009-11-02       Impact factor: 3.164

7.  Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine.

Authors:  Narendra Ram; Sonia Aroui; Emilie Jaumain; Hicham Bichraoui; Kamel Mabrouk; Michel Ronjat; Hugues Lortat-Jacob; Michel De Waard
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

Review 8.  Phosphoinositide signaling: new tools and insights.

Authors:  Tamas Balla; Zsofia Szentpetery; Yeun Ju Kim
Journal:  Physiology (Bethesda)       Date:  2009-08

9.  The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis.

Authors:  Kathryn P Greenwood; Norelle L Daly; Darren L Brown; Jennifer L Stow; David J Craik
Journal:  Int J Biochem Cell Biol       Date:  2007-07-07       Impact factor: 5.085

Review 10.  PI-loting membrane traffic.

Authors:  Maria Antonietta De Matteis; Anna Godi
Journal:  Nat Cell Biol       Date:  2004-06       Impact factor: 28.824

View more
  44 in total

Review 1.  Chemical synthesis of circular proteins.

Authors:  James P Tam; Clarence T T Wong
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 2.  Biological synthesis of circular polypeptides.

Authors:  Teshome L Aboye; Julio A Camarero
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

3.  Membrane Oxidation Enables the Cytosolic Entry of Polyarginine Cell-penetrating Peptides.

Authors:  Ting-Yi Wang; Yusha Sun; Nandhini Muthukrishnan; Alfredo Erazo-Oliveras; Kristina Najjar; Jean-Philippe Pellois
Journal:  J Biol Chem       Date:  2016-02-17       Impact factor: 5.157

4.  Rapid parallel synthesis of bioactive folded cyclotides by using a tea-bag approach.

Authors:  Teshome Aboye; Yuting Kuang; Nouri Neamati; Julio A Camarero
Journal:  Chembiochem       Date:  2015-02-06       Impact factor: 3.164

Review 5.  Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Authors:  Dipankar Chaudhuri; Teshome Aboye; Julio A Camarero
Journal:  Biochem J       Date:  2019-01-11       Impact factor: 3.857

6.  Degradation of an old human protein: age-dependent cleavage of γS-crystallin generates a peptide that binds to cell membranes.

Authors:  Michael G Friedrich; Jackson Lam; Roger J W Truscott
Journal:  J Biol Chem       Date:  2012-09-20       Impact factor: 5.157

7.  Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.

Authors:  Ziqing Qian; Xiaohua Xu; Jeanine F Amacher; Dean R Madden; Estelle Cormet-Boyaka; Dehua Pei
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-17       Impact factor: 15.336

8.  Expression of fluorescent cyclotides using protein trans-splicing for easy monitoring of cyclotide-protein interactions.

Authors:  Krishnappa Jagadish; Radhika Borra; Vanessa Lacey; Subhabrata Majumder; Alexander Shekhtman; Lei Wang; Julio A Camarero
Journal:  Angew Chem Int Ed Engl       Date:  2013-01-15       Impact factor: 15.336

Review 9.  Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.

Authors:  Julio A Camarero
Journal:  Bioorg Med Chem Lett       Date:  2017-10-21       Impact factor: 2.823

10.  Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity.

Authors:  Teshome L Aboye; Helen Ha; Subhabrata Majumder; Frauke Christ; Zeger Debyser; Alexander Shekhtman; Nouri Neamati; Julio A Camarero
Journal:  J Med Chem       Date:  2012-11-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.